Bend Research Receives Two U.S. Patents for Technology to Enhance the Bioavailability of Low-Solubility Drugs  
10/11/2012 9:50:21 AM

BEND, Ore.--(BUSINESS WIRE)--Bend Research Inc. (, a leading independent drug-formulation development and manufacturing company, announced that it has received two new U.S. patents related to its pioneering efforts to improve the oral bioavailability of low-solubility drugs.